Le faux médicament, késako ?

A partir du 1er juillet 2015 et pour une durée de 6 mois, l’Institut de Recherche Anti-Contrefaçon de Médicaments (IRACM) lance une campagne de sensibilisation et d’information auprès du grand public et des patients français sur les risques liés à la consommation de médicaments contrefaits ou falsifiés. Cette campagne est déployée dans les salles d’attente des médecins généralistes à Paris et en Ile-de-France, et en région Provence-Alpes-Côte d’Azur, ainsi que dans les salles d’attentes des Read more…

Quality Matters: Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines

This article was originally published in Quality Matters. Global Health // June 30, 2015 Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines For nearly two centuries, USP has helped secure the quality of the American drug supply. USP’s drug standards are enforceable in the United States by the U.S. Food and Drug Administration (FDA), and these standards are used in more than 140 countries. Despite the efforts of USP and other pharmacopeias to Read more…

“All you need to know about Spurious Medicines”, A Guidebook

The International Pharmaceutical Federation (FIP), in cooperation with the Indian Pharmaceutical Association, has developed a handbook for healthcare professionals entitled “All you need to know about spurious medicines”, which contains tips on preventing and detecting counterfeit medicines as well as advice on how to minimise the threat and change behaviours. Launched as part of the WHPA campaign on March 30th, 205 in New Delhi, the handbook aims to raise awareness and develop competencies of healthcare Read more…

Subscribe to our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.